Abstract The American Cancer Society (ACS) released updated cervical cancer screening
guidelines in 2020 that endorse a shift in practice to primary human papillomavirus (HPV) …

Screening in women has decreased the incidence and mortality of cervical cancer.
Precancerous cervical lesions (cervical intraepithelial neoplasias) and cervical carcinomas …

Persistent high-risk human papillomavirus (HPV) infection is a necessary precursor for the
development of cervical cancer. Recent data demonstrating the sensitivity of HPV testing …

These NCCN Guidelines Insights focus on recent recommendations for cervical cancer
screening and management of abnormal screening tests. When the NCCN Panel convened …

Over the past year, cervical cancer screening guidelines have undergone a series of
important revisions by major organizations. In March, the American Cancer Society (ACS) …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Primary care providers are uniquely poised to prevent, screen, and diagnose cervical
cancer. What started with the Papanicalaou smear in the 1940s, 1 has evolved into multiple …

In July 2020, the American Cancer Society (ACS) released an updated cervical cancer
screening guideline calling for primary human papillomavirus (HPV) screening as the …

Opinion statement Since the publication of the American Cancer Society (ACS)/American
Society for Colposcopy and Cervical Pathology (ASCCP)/American Society for Clinical …

In the coming decade, primary testing for human papillomavirus (HPV) will likely become the
standard of care for cervical cancer screening in both low-and high-resource settings. This …